IL17A and atherosclerosis: The development and progression of atherosclerosis are reported to be strongly related to the cellular factors and inflammatory response in the body, and the associated treatment can focus on controlling inflammation.[27–30] IL-17 is the main cytokine produced by Th17 and tcrγδ + t cells.